New Analyses Advance Understanding of Long-Term Survival Outcomes with Mogamulizumab in Mycosis Fungoides and Sézary Syndrome

Advanced analytical methods integrating clinical trial and real-world data address key evidence gaps in rare, difficult-to-treat blood cancers Across both studies, mogamulizumab was associated with improved survival outcomes compared to standard of care PRINCETON, N.J., June 30, 2026 (GLOBE NEWSWIRE) — Researchers at the World Congress of Cutaneous Lymphoma 2026

Read More

CGTN: From the people, for the people: What the July 1 Medal honors

BEIJING, June 30, 2026 (GLOBE NEWSWIRE) — CGTN has published an article exploring the values embodied by the July 1 Medal. Through the stories of this year’s recommended nominees, the article highlights how generations of the Communist Party of China (CPC) members have remained rooted among the people, dedicated themselves

Read More

Publication relating to transparency notifications.

REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), June 29, 2026, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Law of May 2, 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received transparency notifications

Read More